StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > DOWN

<< Previous

Bullboard Posts

Next >>

Comment by Liked2Thinkon Jun 23, 2021 11:05am

111 Views

Post# 33434218

RE:RE:DOWN

yes

back when we were at 1.60 it wouldnt had been so bad. Now at 50 cents the market wont like it at all unless Tripp has a massive NR to release with it. Im talking a big name signing up to use aristotle. Not some tiny company with a few employees that no one has ever heard about before that we have to buy.

<< Previous

Bullboard Posts

Next >>

What will the U.S. election results mean for Canada?